Safety profile of the yellow fever vaccine Stamaril®: a 17-year review

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010

(2013) J.G. Breugelmans et al.   VACCINE

Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children

(2013) Emmanuel Feroldi et al.   Human Vaccines & Immunotherapeutics

Review of the risks and benefits of yellow fever vaccination including some new analyses

(2012) Thomas P Monath   Expert Review of Vaccines

Viscerotropic disease: Case definition and guidelines for collection, analysis, and presentation of immunization safety data

(2012) Mark D. Gershman et al.   VACCINE

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine

(2011) Peter E Nasveld et al.   Human vaccines & immunotherapeutics

The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever

(2011) Emily S Jentes et al.   LANCET INFECTIOUS DISEASES

Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review

(2011) Roger E. Thomas et al.   VACCINE

From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

(2011) Bruno Guy et al.   VACCINE

Evaluation of two yellow fever vaccines for routine immunization programs in Argentina

(2010) Carlos Ripoll et al.   Human vaccines & immunotherapeutics

Incidence of Yellow Fever Vaccine-Associated Neurotropic Disease

(2009) Thomas Guimard et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Clinical and Immunological Insights on Severe, Adverse Neurotropic and Viscerotropic Disease following 17D Yellow Fever Vaccination

(2009) M. L. Silva et al.   Clinical and Vaccine Immunology

Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV‐Infected Patients

(2009) Olivia Veit et al.   CLINICAL INFECTIOUS DISEASES

Safety of 17D derived yellow fever vaccines

(2009) Cristina Domingo et al.   Expert Opinion On Drug Safety

The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response

(2009) R. S. Akondy et al.   JOURNAL OF IMMUNOLOGY

TLR expression and NK cell activation after human yellow fever vaccination

(2009) Patrícia Cristina da Costa Neves et al.   VACCINE

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

(2009) Bruno Guy et al.   VACCINE

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

(2008) Denis Gaucher et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Immune Response during Adverse Events after 17D‐Derived Yellow Fever Vaccination in Europe

(2008) Hi‐Gung Bae et al.   JOURNAL OF INFECTIOUS DISEASES

Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes

(2008) Bali Pulendran et al.   JOURNAL OF INFECTIOUS DISEASES

Yellow Fever–Associated Viscerotropic Disease in Barcelona, Spain

(2008) Jose Muñoz et al.   JOURNAL OF TRAVEL MEDICINE

Adverse event reports following yellow fever vaccination

(2008) Nicole P. Lindsey et al.   VACCINE